Trials / Completed
CompletedNCT01800877
Optimal VAsopressor titraTION Pilot Randomized Controlled Trial
Optimal Vasopressor Titration Pilot Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Francois Lamontagne · Academic / Other
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to determine if it is better to give vasopressors to patients to maintain a higher blood pressure target versus a lower blood pressure target. This study is important because the information we find out will help us know how best to administer vasopressors in patients with shock in the ICU.
Detailed description
Patients who are admitted to the intensive care unit (ICU) commonly suffer from shock, a condition that causes life-threatening low blood pressure. Low blood pressure makes it difficult for the body to deliver blood to all of its organs. The standard treatment doctors in the ICU use for their patients is to give medications that help increase blood pressure. These medications are called vasopressors. There can be side effects related to using vasopressors. The purpose of this research study is to determine if it is better to give vasopressors to patients to maintain a higher blood pressure target versus a lower blood pressure target. This study is important because the information we find out will help us know how best to administer vasopressors in patients with shock in the ICU.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vasopressors |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2014-12-01
- Completion
- 2015-02-01
- First posted
- 2013-02-28
- Last updated
- 2019-03-12
- Results posted
- 2019-03-12
Locations
10 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01800877. Inclusion in this directory is not an endorsement.